Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6.922,00 JPY | +2,47% |
|
+2,79% | -1,10% |
Bedrijfswaardering: Chugai Pharmaceutical Co., Ltd
Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Marktkapitalisatie 1 | 5.518.359 | 9.045.924 | 6.141.311 | 5.540.406 | 8.789.053 | 11.390.330 | 11.390.330 | - |
Variatie | - | 63,92% | -32,11% | -9,78% | 58,64% | 29,6% | 0% | - |
Bedrijfswaarde 1 | 5.185.301 | 8.667.304 | 5.669.311 | 5.051.408 | 8.050.071 | 10.520.608 | 10.413.018 | 10.190.041 |
Variatie | - | 67,15% | -34,59% | -10,9% | 59,36% | 30,69% | -1,54% | -2,14% |
P/E-ratio | 35x | 42,1x | 20,3x | 14,8x | 27x | 29,7x | 28x | 25,8x |
PBR-ratio | 6,46x | 9,23x | 5,17x | 3,89x | 5,41x | 6,06x | 5,44x | 4,94x |
PEG | - | 1,2x | 0,5x | 0,6x | -2,1x | 1,6x | 7,53x | 2,98x |
Marktkapitalisatie/omzet | 8,04x | 11,5x | 6,14x | 4,4x | 7,91x | 9,84x | 9,63x | 9,3x |
Bedrijfswaarde/omzet | 7,56x | 11x | 5,67x | 4,01x | 7,24x | 8,99x | 8,8x | 8,32x |
Bedrijfswaarde/EBITDA | 22,5x | 26,1x | 12,3x | 8,93x | 17,1x | 18,3x | 17,5x | 17,3x |
Bedrijfswaarde/EBIT | 24,6x | 28,8x | 13,4x | 9,47x | 18,3x | 19,4x | 18,8x | 17,2x |
Bedrijfswaarde/FCF | 41,5x | 81,2x | 35,3x | 27,7x | 21,6x | 47,8x | 30,9x | 28,8x |
FCF Yield | 2,41% | 1,23% | 2,83% | 3,61% | 4,63% | 2,09% | 3,23% | 3,47% |
Dividend per aandeel 2 | 46,67 | 55 | 76 | 78 | 80 | 98 | 99,38 | 104 |
Rendement | 1,39% | 1% | 2,03% | 2,32% | 1,5% | 1,4% | 1,44% | 1,5% |
WPA 2 | 95,95 | 130,7 | 184,3 | 227,6 | 197,8 | 235,4 | 247 | 268,4 |
Uitkeringspercentage | 48,6% | 42,1% | 41,2% | 34,3% | 40,4% | 41,6% | 40,2% | 38,7% |
Omzet 1 | 686.184 | 786.900 | 999.800 | 1.259.946 | 1.111.367 | 1.170.611 | 1.182.895 | 1.224.799 |
EBITDA 1 | 230.967 | 332.600 | 459.100 | 565.376 | 470.914 | 573.667 | 593.962 | 590.049 |
EBIT 1 | 210.597 | 301.200 | 421.900 | 533.309 | 439.174 | 542.002 | 555.185 | 591.311 |
Nettowinst (verlies) 1 | 157.560 | 214.700 | 303.000 | 374.429 | 325.472 | 387.317 | 406.426 | 431.426 |
Nettoschuld 1 | -333.058 | -378.620 | -472.000 | -488.998 | -738.982 | -996.345 | -977.311 | -1.200.289 |
Referentiekoers 2 | 3.360,00 | 5.503,00 | 3.735,00 | 3.368,00 | 5.342,00 | 6.922,00 | 6.922,00 | 6.922,00 |
Aantal aandelen (in duizend) | 1.642.369 | 1.643.817 | 1.644.260 | 1.645.014 | 1.645.274 | 1.645.526 | 1.645.526 | - |
Datum van publicatie | 30-01-20 | 04-02-21 | 03-02-22 | 02-02-23 | 01-02-24 | 30-01-25 | - | - |
P/E-ratio, Gedetailleerde evolutie
Toevoegen aan een lijst 0 geselecteerde | P/E-ratio (Y) | EV/omzet (Y) | Beurskap. / EBITDA (Y) | Dividendrendement (Y) | Kapi.($) | |
---|---|---|---|---|---|---|
29.06x | 9.13x | 18.33x | 1,29% | 75,33 mld. | ||
71.35x | 18.03x | 50.39x | 0,59% | 791 mld. | ||
22.95x | 8.11x | 15.8x | 2,2% | 387 mld. | ||
22.11x | 4.28x | 12.49x | 3,11% | 369 mld. | ||
43.27x | 7.06x | 16.27x | 3,27% | 337 mld. | ||
15.07x | 3.75x | 9.24x | 3,42% | 255 mld. | ||
26.98x | 4.6x | 14.53x | 2,16% | 223 mld. | ||
12.45x | 3.8x | 9.13x | 3,52% | 221 mld. | ||
16.71x | 4.2x | 10.15x | 3,58% | 210 mld. | ||
32.15x | 6.24x | 10.96x | 3,08% | 158 mld. | ||
Gemiddelde | 29,21x | 6,92x | 16,73x | percentage-no-prefix | 302,55 mld. | |
Gewogen gemiddelde per kap. | 36,83x | 8,83x | 22,78x | percentage-no-prefix |
Historische koers/winstverhouding
Evolutie van de historische PBR-ratio
Evolutie bedrijfswaarde/omzet
Historische marktkapitalisatie/EBITDA
Evolutie van de historische prestaties
- Beurs
- Aandelen
- Koers 4519
- Totale waarde Chugai Pharmaceutical Co., Ltd